Press "Enter" to skip to content

New patent expiration for Novartis drug GLEEVEC

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Novartis drug GLEEVEC

Annual Drug Patent Expirations for GLEEVEC
Annual Drug Patent Expirations for GLEEVEC

Gleevec is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There is one patent protecting this drug and two Paragraph IV challenges.

GLEEVEC drug price trends.

Drug patent litigation for GLEEVEC.

The generic ingredient in GLEEVEC is imatinib mesylate. One supplier is listed for this compound. Additional details are available on the imatinib mesylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Novartis drug GLEEVEC
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions